Taste of M&A Mon­day; A spe­cial kind of lab; Biotech founder wins No­bel; Bio­Marin lay­offs; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Zoom can on­ly go so far. That’s the mind­set John Car­roll will be bring­ing to Lon­don next week for the first time in sev­er­al years. If you’re there, con­sid­er join­ing him as he chats with a small crowd of bio­phar­ma peo­ple — we al­so have vir­tu­al op­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER